Search Results for “diagnostic” – Page 11 – media

The National Medical Insurance Administration responded to the next direction of the centralized procurement of consumables

Recently, the National Medical Insurance Administration issued the “Reply of the National Medical Insurance Administration to Suggestion No. 2090 of the Second Session of the Fourteenth National People’s Congress” (hereinafter referred to as the “Reply”). In the “Reply”, the National Medical Insurance Administration explained the next steps for the centralized procurement of consumables and the implementation of innovative medical devices. In particular, the next steps for local centralized procurement were explained. The “Reply” pointed out that centralized procurement is still in the stage of reform and overcoming difficulties. The National Medical Insurance Administration will further supervise and improve the rules of local centralized procurement, improve the scientificity and standardization of local centralized procurement, and improve the quality and efficiency of procurement. First, expand the scope of the alliance and strengthen national coordination. Encourage local governments to carry out alliance procurement, and upgrade to national alliance procurement if conditions are met. ...
- Source: drugdu
- 73
- October 9, 2024
14 major consumables enter price reduction period

At the end of September, the National Joint Procurement Platform for High-value Medical Consumables issued the “Notice on the Centralized Maintenance of Cochlear Implants and Peripheral Interventional Medical Consumables”. At present, many provinces have begun to start the historical procurement data reporting work for this national procurement. The reporting subjects are public medical institutions that use cochlear implants and peripheral interventional medical consumables in 2022 and 2023. The deadline is around October 16 and 17. At 15:00 on October 8, the National Joint Procurement Office for High-value Medical Consumables will introduce the system operation through video conferencing, and provide training videos and other materials for use by various medical institutions. Peripheral intervention is one of the few varieties that have not yet been purchased on a large scale. This national procurement is bound to have a major impact on this field. In 2021, Henan’s centralized procurement of neuro-interventional and peripheral ...
- Source: drugdu
- 78
- October 9, 2024
To build China’s own blood brand

In recent years, China’s blood gas analyzer market has shown a strong development trend, especially in critical illness, emergency and surgical scenarios, and the scale has expanded dramatically. At present, the market size of blood gas analysis in China is about 2.7 billion yuan, and the industry growth rate is about 20%. From the perspective of market share, imported brands have the first-mover advantage in R&D and market, according to the data reported by the China Research Institute of Puhua Industry Research Institute, about 80% of the current market share of the domestic blood gas analyzer market is still occupied by imported brands, mainly for Radiometer, Wolfen, Abbott, etc., and domestic brands are mainly represented by the head brand of blood gas. According to the statistics of the bidding network, in the first half of 2024, the scale and demand for blood gas equipment procurement across the country ...
- Source: https://mp.weixin.qq.com
- 94
- October 4, 2024
KIMES BUSAN

Organiser：E&EX Exhibition Company, Korea Time：October 18 – 20, 2024 Address：55 Apec-ro, Haeundae-gu, Busan, 612-704, South Korea Exhibition hall：Busan Exhibition & Convention Center Product range: Medical Equipment: Medical technology equipment, consumables, medical electronic devices, ophthalmic equipment & protective products, surgical instruments, emergency response equipment, hospital, dental, & medical facilities, dental service equipment & disposable medical products, hospital & household disposable medical products, hospital dentistry, medical data processing systems, dental plastic surgery, rehabilitation equipment, etc. In Vitro Diagnostics & Clinical Laboratory Equipment: Endoscopy systems, B-mode ultrasound, examination equipment, ENT treatment instruments, dynamic analysis instruments, total laboratory solutions, clinical diagnostic equipment, diagnostic reagents, precision medicine, POCT (Point-of-Care Testing) home diagnostic devices, clinical laboratory equipment. Rehabilitation & Nursing Supplies: Orthopedic devices, walkers, hearing aids, audio guide systems for visually impaired, manual wheelchairs, electric wheelchairs, crutches, walking aids, massagers, healthcare apparel, fitness equipment, training machines, wrist & ankle braces, wearable neck braces, back braces, ...
- Source: drugdu
- 97
- October 3, 2024
“The leader of narcotics” in China, the actual controller may change hands

On September 25, Humanwell Pharmaceutical announced that it had received a “Notification Letter on the Company’s Application for Reorganization” from Wuhan Contemporary Technology Industry Group Co., Ltd. (hereinafter referred to as “Modern Technology”), the controlling shareholder of the company, the day before, and Wuhan Credit Risk Management Financing Guarantee Co., Ltd. and Tianjin Shengcao Law Firm had applied to the Intermediate People’s Court of Wuhan City, Hubei Province for the reorganization of Modern Technology. At present, Humanwell Pharma has not received the documents of the Wuhan Intermediate People’s Court on the acceptance of the above-mentioned application for reorganization, and it is not yet known whether the court will accept it and whether Modern Technology will enter the reorganization procedure in the future. In this regard, many investors took the lead in voting in favor, believing that the replacement of the major shareholder of Modern Technology will be more conducive to ...
- Source: https://mp.weixin.qq.com
- 99
- October 3, 2024
Cell | Ma Kaiyue et al. develop a new method for high-throughput functional identification of mutations

The analysis of pathogenic genetic variations has always been an important challenge in the field of human genetics. Single nucleotide mutations in genes related to Mendelian genetic diseases should be the easiest type of mutation to study in human genetics. However, for many disease genes, the clinical importance of at least half of single nucleotide mutations has not been determined, seriously affecting the diagnostic efficiency of genetic diseases, especially rare genetic diseases. Deep mutational screening (DMS) refers to a research method that generates large-scale gene variations through saturation mutagenesis and then studies genetic variations in cell lines through high-throughput methods. This method can greatly accelerate the diagnosis of genetic diseases and deepen our understanding of the clinical importance of single nucleotide mutations. However, the cost and complexity of current deep mutation screening methods hinder their widespread application in clinical research. On September 25, 2024, Monkol Lek’s team from Yale ...
- Source: BioArt
- 93
- October 2, 2024
Medexpo Tanzania

Organiser：EXPOGROUP Time：October 9 – 11, 2024 Address：Aga Khan Diamond Jubilee Hall, P.O.Box 7750, Malik Road, Upanga West, Dar es Salaam, Tanzania Exhibition hall：Aga Khan Diamond Jubilee Hall Product range: Hospital Equipment & Supplies: Patient Rehabilitation & Wellness Services, Hospital Furniture & Management, IT & Telecommunication, Ambulances & Transportation Equipment, Surgical Gowns, Medical Consumables, Water Treatment Equipment, Cleaning Equipment & Services, Biotechnology, etc. Medical Devices & Laboratory Equipment: Respiratory Devices, Imaging Equipment, Surgical Instruments & Supplies, Diagnostic Equipment & Instruments, Dialysis Equipment, EEG & ECG Machines, Endoscopes & Accessories, UV & IR Radiation Equipment, Thermotherapy Devices, Ultrasound Diagnostic Equipment, Heating Systems, Cardiac Catheterization Equipment, Medical Lighting Products, MRI Scanners, Oxygen Supply Equipment, Sterilization & Disinfection Equipment, Urinary Catheters, Colposcopes, Disposable Items, Cryosurgical Equipment, Laser Surgical Equipment, Laser Therapy Devices, Lithotripsy Machines, Laboratory Equipment & Supplies, etc. Dental Equipment: Dental Tools, Equipment, Surgical Instruments, Dental Care Products & Medicines, Artificial Teeth ...
- Source: drugdu
- 93
- October 1, 2024
What Are Its Treatment Prospects?

Recently, according to publicly available information from the Center for Drug Evaluation (CDE) of the National Medical Products Administration, the technetium-99m ([99mTc]) hydrazinonicotinamide polyethylene glycol RGD peptide injection (referred to as “99mTc-3PRGD2”) developed by Ruidiao Pharmaceuticals has been included in the priority review list. This also applies to the injection of toluenesulfonate hydrazone nicotinamide polyethylene glycol RGD peptide. 99mTc-3PRGD2 is a radiolabeled drug conjugate (RDC) independently developed by Ruidiao Pharmaceuticals. It is the first class I new drug for radiologic diagnosis in nuclear medicine in China and the world’s first broad-spectrum tumor imaging agent for SPECT imaging. Notably, the success of this drug’s development will change the current technical status and conventional understanding that SPECT/CT imaging technology in nuclear medicine cannot be used for tumor diagnosis, staging, and efficacy evaluation. According to Ruidiao Pharmaceuticals, 99mTc-3PRGD2 targets integrin and specifically binds to the integrin αvβ3 receptor on tumor neovascularization, demonstrating high ...
- Source: drugdu
- 85
- September 30, 2024
CT angiography image assisted detection software for intracranial aneurysms approved for market launch

On September 25th, the National Medical Products Administration announced that it has recently approved the registration application for the innovative product “CT angiography image assisted detection software for intracranial aneurysms” of Shanghai Lianying Intelligent Medical Technology Co., Ltd. (hereinafter referred to as “Lianying Intelligent”). Effective improvement, innovative products begin to emerge Lianying Intelligence is an artificial intelligence company under Lianying Group, established in Shanghai at the end of 2017. It is an important strategic layout of Lianying Group in the field of artificial intelligence. Relying on the high-performance software and hardware technology platform and resource advantages of Lianying Group, Lianying Intelligence has become a medical AI enterprise that can provide multi scenario, multi disease, full process, and integrated intelligent solutions. It empowers clinical, scientific research, and equipment with AI, covering multiple AI application scenarios such as hospital level management, medical innovation ecology, workflow optimization, precision diagnosis and treatment, and personal ...
- Source: drugdu
- 74
- September 28, 2024
Novartis plans to give priority review to two “nuclear medicine-related products”

Today (September 24), CDE plans to include Novartis’ Lutetium [177Lu] Texivirpitide Injection and Radioactive Drug Gallium [68Ga] Gozertide Injection Preparation Kit in the priority review. According to the CDE official website, both drugs are based on the “Opinions of the National Medical Products Administration on Reforming and Improving the Management System for the Review and Approval of Radioactive Drugs” (National Medical Products Administration Drug Note [2023] No. 20) and the “Medium- and Long-Term Development Plan for Medical Isotopes (2021-2035)”. After review, they comply with the “Drug Registration Management Measures” and the “Announcement of the National Medical Products Administration on the Release of the “Breakthrough Therapeutic Drug Review Work Procedures (Trial)” and other three documents (No. 82 of 2020). The requirements are agreed to be included in the priority review and approval procedure according to the priority review scope “(VI) Other circumstances prescribed by the National Medical Products Administration for priority ...
- Source: drugdu
- 67
- September 28, 2024

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.